Sir, We encountered a 66-year-old woman with bullous pemphigoid (BP) that developed on lichen sclerosus et atrophicus (LSA) lesions.
The patient suffered from LSA for 12 years. While LSA most commonly affects the vulval area, her LSA involved the trunk, extremities, and the anogenital skin. [1] Topical treatment with corticosteroids and tacrolimus yielded limited success.
Tense bullae appeared on the sclerotic LSA lesions in the genital region 12 years after the diagnosis of LSA [ Figure 1a and b]. The bullous lesions spread to the skin on the abdomen and chest affected by LSA. Her serum BP antibody, BP180, was 46.9 U/ml (chemiluminescence enzyme immunoassay). Skin biopsies from her abdomen and genitalia revealed subepidermal cleft with predominant eosinophilic infiltration [ Figure 1c and d]. In the upper dermis, we noted pronounced edema and collagen homogenization [ Figure 1c and e]. Direct immunofluorescence study of the same specimens revealed linear deposits of immunoglobulin G in the basement membrane zone [ Figure 1f ]. The above findings led to the diagnosis of BP arising on LSA. Oral prednisolone (PSL, 30 mg/day) was started. The bullous lesions improved quickly, and her autoantibodies became negative. The PSL dose was gradually tapered to 10 mg, and she suffered no relapse in 1 year.
Although the etiology and pathogenesis of LSA are not fully understood, they are thought to be multifactorial with the involvement of autoimmune-related factors. [2] [3] [4] Our review of the English literature found only three cases of BP associated with LSA. [2] [3] [4] [5] Meyrick Thomas et al. [2] who investigated autoimmune-related phenomena in 350 women with histologically confirmed LSA demonstrated that 21.5% had one or more autoimmune diseases including alopecia areata (9%), vitiligo (6%), hypothyroidism (6%), and BP (1%); 42% presented with an autoantibody. With respect to autoantibodies against BP antigens, Baldo et al. [3] reported that the noncollagenous 16A domain of BP180 was a target for circulating T-cells in over 40% of their patients with vulval lichen sclerosus or lichen planus; 4 of 19 manifested associated autoantibodies to BP180. A lichen sclerosus cohort study of 149 patients revealed elevated anti-BP antibodies in 5 (3.4%), BP180 in 4, and BP230 in one patient. [4] These studies suggested an immunogenetic connection between LSA and anti-BP autoantibodies. Ours was a rare case of BP with LSA and further studies to examine the pathological role of anti-BP autoantibodies produced in LSA patients who develop associated BP are needed.
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The authors certify that they have obtained all appropriate patient consent forms. In the form the patient(s) has/have given his/her/their consent for his/her/their images and other clinical information to be reported in the journal. The patients understand that their names and initials will not be published and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed. Sir, A 54-year-old Chinese male presented with a 2-month history of recurrent fever and 1-month history of multiple enlarged superficial lymph nodes. He was admitted in our hospital on December 9, 2016. The history of the patient was not remarkable except that he had consumed bamboo rats a year ago. Physical examination showed enlarged left cervical, bilateral retroauricular, supraclavicular, and inguinal lymph nodes. He subsequently developed skin lesions which showed painful erythematous papules, plaques, pustules, and edematous erythema over the face, dorsa of hands, and lower extremities [ Figure 1a- Figure 1d ]. Amphotericin B 10 mg/ day was given at an incremental dose of 10 mg/day until 50 mg/day. After that, the dose was maintained. At the same time, fluconazole was replaced with itraconazole 0.2 g b.i.d. With modification to the treatment regimen, the skin lesions improved gradually and the patient was better. However, recurrent fever
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